Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Polycystic kidneys have decreased vascular density: a micro-CT study.

Xu R, Franchi F, Miller B, Crane JA, Peterson KM, Psaltis PJ, Harris PC, Lerman LO, Rodriguez-Porcel M.

Microcirculation. 2013 Feb;20(2):183-9. doi: 10.1111/micc.12022.

2.

Mesenchymal Stromal Cells Improve Renovascular Function in Polycystic Kidney Disease.

Franchi F, Peterson KM, Xu R, Miller B, Psaltis PJ, Harris PC, Lerman LO, Rodriguez-Porcel M.

Cell Transplant. 2015;24(9):1687-98. doi: 10.3727/096368914X684619. Epub 2014 Oct 6.

3.

Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease.

Peterson KM, Franchi F, Loeffler DL, Psaltis PJ, Harris PC, Lerman LO, Lerman A, Rodriguez-Porcel M.

Am J Nephrol. 2013;38(3):233-40. doi: 10.1159/000354236. Epub 2013 Aug 30.

4.

Renal endothelin system in polycystic kidney disease.

Hocher B, Zart R, Schwarz A, Vogt V, Braun C, Thöne-Reineke C, Braun N, Neumayer HH, Koppenhagen K, Bauer C, Rohmeiss P.

J Am Soc Nephrol. 1998 Jul;9(7):1169-77.

5.

Role of renal microcirculation in experimental renovascular disease.

Iliescu R, Fernandez SR, Kelsen S, Maric C, Chade AR.

Nephrol Dial Transplant. 2010 Apr;25(4):1079-87. doi: 10.1093/ndt/gfp605. Epub 2009 Nov 23.

6.

Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.

Braun C, Lüdicke C, Rebsch W, Gretz N, van der Woude FJ, Rohmeiss P.

Nephrol Dial Transplant. 1996;11 Suppl 6:52-7.

PMID:
9044329
7.

Three-dimensional microcomputed tomography of renal vasculature in rats.

Garcia-Sanz A, Rodriguez-Barbero A, Bentley MD, Ritman EL, Romero JC.

Hypertension. 1998 Jan;31(1 Pt 2):440-4.

8.

Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.

Braun C, Kleemann T, Hilgenfeldt U, Riester U, Rohmeiss P, van der Woude FJ.

Kidney Int. 2002 Jun;61(6):2149-56.

9.

Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.

Gattone VH 2nd, Kuenstler KA, Lindemann GW, Lu X, Cowley BD Jr, Rankin CA, Calvet JP.

J Lab Clin Med. 1996 Feb;127(2):214-22.

PMID:
8636651
10.

Renal circulation and cellular metabolism during left ventricular assisted circulation: comparison study of pulsatile and nonpulsatile assists.

Sezai A, Shiono M, Orime Y, Nakata K, Hata M, Yamada H, Iida M, Kashiwazaki S, Kinishita J, Nemoto M, Koujima T, Sezai Y, Saitoh T.

Artif Organs. 1997 Jul;21(7):830-5.

PMID:
9212968
11.

The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.

Lager DJ, Qian Q, Bengal RJ, Ishibashi M, Torres VE.

Kidney Int. 2001 Jan;59(1):126-36.

12.

Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension.

Rodriguez-Porcel M, Zhu XY, Chade AR, Amores-Arriaga B, Caplice NM, Ritman EL, Lerman A, Lerman LO.

Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H978-84. Epub 2005 Oct 7. Erratum in: Am J Physiol Heart Circ Physiol. 2006 May;290(5):H2163.

13.

Novel methods for microCT-based analyses of vasculature in the renal cortex reveal a loss of perfusable arterioles and glomeruli in eNOS-/- mice.

Perrien DS, Saleh MA, Takahashi K, Madhur MS, Harrison DG, Harris RC, Takahashi T.

BMC Nephrol. 2016 Mar 2;17:24. doi: 10.1186/s12882-016-0235-5.

14.

Microcomputed tomography of kidneys following chronic bile duct ligation.

Ortiz MC, García-Sanz A, Bentley MD, Fortepiani LA, García-Estañ J, Ritman EL, Romero JC, Juncos LA.

Kidney Int. 2000 Oct;58(4):1632-40.

16.

Expression and actions of heme oxygenase in the renal medulla of rats.

Zou AP, Billington H, Su N, Cowley AW Jr.

Hypertension. 2000 Jan;35(1 Pt 2):342-7.

17.

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ.

Am J Kidney Dis. 2001 Mar;37(3):601-11.

PMID:
11228186
18.

Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.

Chade AR, Kelsen S.

Am J Physiol Renal Physiol. 2012 May 15;302(10):F1342-50. doi: 10.1152/ajprenal.00674.2011. Epub 2012 Feb 22.

19.

Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease.

Ding A, Kalaignanasundaram P, Ricardo SD, Abdelkader A, Witting PK, Broughton BR, Kim HB, Wyse BF, Phillips JK, Evans RG.

Clin Exp Pharmacol Physiol. 2012 Nov;39(11):917-29. doi: 10.1111/1440-1681.12013.

PMID:
23006058
20.

Age-Related Alterations in Blood Biochemical Characterization of Hepatorenal Function in the PCK Rat: A Model of Polycystic Kidney Disease.

Shimomura Y, Brock WJ, Ito Y, Morishita K.

Int J Toxicol. 2015 Nov-Dec;34(6):479-90. doi: 10.1177/1091581815611075. Epub 2015 Oct 25.

PMID:
26503599

Supplemental Content

Support Center